GSK's Paracetamol ER Expected Back In India In Two Weeks At Lower Cost

Although GlaxoSmithKline has agreed to cut in half its price for Crocin Advanced (paracetamol) painkiller in India, the company expects its drug to remain in short supply as it adjusts the label and gets it back in stores. GlaxoSmithKline Consumer Healthcare LP pulled the over-the-counter drug from India's market as it sought an exemption from national price controls on grounds the extended-release version was innovative. The exemption was denied, and GSK was forced to meet a price half that it was charging. Pharmacists expect to have the drug to sell within two weeks. Cipla and Ranbaxy Laboratories also sell paracetamol-based brands. (Click here for more

)